Flt3 tyrosine kinase inhibitors (St Jude Children's Research Hospital/Ohio State University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFlt3 tyrosine kinase inhibitors (St Jude Children's Research Hospital/Ohio State University)
Drug Alias NameFlt3 tyrosine kinase inhibitors (St Jude Children's Research Hospital)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSt. Jude Children'S Research Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSt. Jude Children'S Research HospitalThe Ohio State University
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A